ES2191963T3 - Derivados triciclicos de triazolobenzazepina, proceso para la obtencion de los mismos y agentes antialergicos. - Google Patents

Derivados triciclicos de triazolobenzazepina, proceso para la obtencion de los mismos y agentes antialergicos.

Info

Publication number
ES2191963T3
ES2191963T3 ES98944289T ES98944289T ES2191963T3 ES 2191963 T3 ES2191963 T3 ES 2191963T3 ES 98944289 T ES98944289 T ES 98944289T ES 98944289 T ES98944289 T ES 98944289T ES 2191963 T3 ES2191963 T3 ES 2191963T3
Authority
ES
Spain
Prior art keywords
alkyl
same
hydrogen atom
triazolobenzazepina
triciclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98944289T
Other languages
English (en)
Inventor
Yasuo Ohtsuka
Toshio Nishizuka
Sohjiro Shiokawa
Seiji Tsutsumi
Mami Kawaguchi
Hideo Kitagawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Seika Kaisha Ltd
Original Assignee
Meiji Seika Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha Ltd filed Critical Meiji Seika Kaisha Ltd
Application granted granted Critical
Publication of ES2191963T3 publication Critical patent/ES2191963T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Un compuesto representado por la fórmula (I) o una sal o un solvato farmacológicamente aceptables del mismo: en la que R1 significa un átomo de hidrógeno, un grupo hidroxilo, alquilo C1-4 o fenil-alquilo C1-4; R2, R3, R4 y R5, que pueden ser iguales o distintos, significan uno cualquiera de los siguientes restos de (a) a (n): (a) un átomo de hidrógeno; (b) un átomo de halógeno; (c) un grupo hidroxilo eventualmente protegido; (d) formilo; (e) alquilo C1-12 que puede estar sustituido por un átomo de halógeno; (f) alquenilo C2-12 que tiene uno o varios dobles enlaces carbono-carbono y puede estar sustituido por (1) un átomo de halógeno, (2) ciano, (3) -COR9 en el que R9 significa un átomo de hidrógeno o alquilo C1-6, (4) -COOR10, en el que R10 significa un átomo de hidrógeno o alquilo C1-6, (5) -CONR11R12 en el que R11 y R12, que pueden ser iguales o distintos.
ES98944289T 1997-09-29 1998-09-29 Derivados triciclicos de triazolobenzazepina, proceso para la obtencion de los mismos y agentes antialergicos. Expired - Lifetime ES2191963T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP26461197 1997-09-29
JP5206398 1998-03-04

Publications (1)

Publication Number Publication Date
ES2191963T3 true ES2191963T3 (es) 2003-09-16

Family

ID=26392670

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98944289T Expired - Lifetime ES2191963T3 (es) 1997-09-29 1998-09-29 Derivados triciclicos de triazolobenzazepina, proceso para la obtencion de los mismos y agentes antialergicos.

Country Status (24)

Country Link
US (3) US6372735B1 (es)
EP (1) EP1026167B1 (es)
JP (1) JP3188482B2 (es)
KR (1) KR100389140B1 (es)
CN (2) CN1312135C (es)
AT (1) ATE233764T1 (es)
AU (1) AU744636B2 (es)
BR (1) BR9814055B1 (es)
CA (1) CA2305307C (es)
DE (1) DE69811930T2 (es)
DK (1) DK1026167T3 (es)
ES (1) ES2191963T3 (es)
HU (1) HUP0004020A3 (es)
ID (1) ID24101A (es)
IL (1) IL135303A0 (es)
NO (2) NO319542B1 (es)
NZ (1) NZ503601A (es)
PL (1) PL339544A1 (es)
PT (1) PT1026167E (es)
RU (1) RU2198885C2 (es)
SK (1) SK283869B6 (es)
TR (1) TR200000808T2 (es)
TW (1) TW510902B (es)
WO (1) WO1999016770A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2346858T3 (es) * 2001-12-26 2010-10-21 Meiji Seika Kaisha Ltd. Sustancia amorfa de un derivado triciclico de triazolobenzazepina.
ATE359277T1 (de) 2002-02-01 2007-05-15 Meiji Seika Kaisha Verfahren zur herstellung einer 1,2,3- triazolverbindung
ATE543497T1 (de) 2002-07-09 2012-02-15 Bristol Myers Squibb Co Substituierte heterozyklische derivate als mittel gegen diabetes und adipositas und verfahren
AU2003259131A1 (en) 2002-07-09 2004-01-23 Bristol-Myers Squibb Company Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
JPWO2004113343A1 (ja) * 2003-06-19 2006-08-31 明治製菓株式会社 三環性トリアゾロベンゾアゼピン誘導体の新規結晶性物質
JPWO2004113451A1 (ja) * 2003-06-20 2006-08-17 明治製菓株式会社 難溶性物質と水溶性高分子との共沈物およびその製造方法
ATE381566T1 (de) 2004-05-14 2008-01-15 Millennium Pharm Inc Verbindungen und verfahren zur inhibierung der mitotischen progression durch hemmung von aurorakinase
WO2007100079A1 (ja) 2006-03-02 2007-09-07 Meiji Seika Kaisha, Ltd. 三環性トリアゾロベンゾアゼピン誘導体を含有する、アレルギー性眼疾患またはアレルギー性鼻疾患の予防または治療剤
US8242105B2 (en) * 2006-09-25 2012-08-14 Forschungsverbund Berlin E.V. Structural mimetics of proline-rich peptides and the pharmaceutical use thereof
CL2007003244A1 (es) * 2006-11-16 2008-04-04 Millennium Pharm Inc Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer.
DE602008004820D1 (de) * 2007-12-18 2011-03-17 Meiji Seika Kaisha Vorbeuge- oder heilmittel für entzündliche darmerkrankungen
ES2468391T3 (es) 2008-12-22 2014-06-16 Millennium Pharmaceuticals, Inc. Combinación de inhibidores de cinasas Aurora y anticuerpos anti-CD20
JO3635B1 (ar) 2009-05-18 2020-08-27 Millennium Pharm Inc مركبات صيدلانية صلبة وطرق لانتاجها
ES2768295T3 (es) * 2010-01-07 2020-06-22 Alkermes Pharma Ireland Ltd Profármacos de compuestos heteroaromáticos
JP2013520424A (ja) 2010-02-19 2013-06-06 ミレニアム ファーマシューティカルズ， インコーポレイテッド ナトリウム４−｛［９−クロロ−７−（２−フルオロ−６−メトキシフェニル）−５Ｈ−ピリミド［５，４−ｄ］［２］ベンゾアゼピン−２−イル］アミノ｝−２−メトキシベンゾエートの結晶形
US20130303519A1 (en) 2012-03-20 2013-11-14 Millennium Pharmaceuticals, Inc. Methods of treating cancer using aurora kinase inhibitors
WO2014153509A1 (en) 2013-03-22 2014-09-25 Millennium Pharmaceuticals, Inc. Combination of catalytic mtorc 1/2 inhibitors and selective inhibitors of aurora a kinase
WO2017015316A1 (en) 2015-07-21 2017-01-26 Millennium Pharmaceuticals, Inc. Administration of aurora kinase inhibitor and chemotherapeutic agents
AR114070A1 (es) * 2017-12-29 2020-07-15 Biomarin Pharm Inc Inhibidores de glicolato oxidasa para el tratamiento de una enfermedad

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69411243T2 (de) 1993-04-16 1998-11-19 Shionogi & Co Verfahren zur herstellung eines lignan-derivats
ES2156933T3 (es) 1993-12-28 2001-08-01 Meiji Seika Co Derivados triciclicos de benzazepina y benzotiazepina.
JP3537446B2 (ja) * 1995-06-15 2004-06-14 明治製菓株式会社 三環性ベンゾアゼピン化合物
NZ330973A (en) * 1996-03-08 2000-03-27 Zeneca Ltd Azolobenzazepine derivatives as neurologically active agents
US20070059533A1 (en) * 2005-09-12 2007-03-15 Burdette Steven R Thermal reflow of glass and fused silica body

Also Published As

Publication number Publication date
WO1999016770A1 (en) 1999-04-08
NO319542B1 (no) 2005-08-29
KR20010030784A (ko) 2001-04-16
IL135303A0 (en) 2001-05-20
TW510902B (en) 2002-11-21
EP1026167A4 (en) 2001-07-11
CA2305307A1 (en) 1999-04-08
KR100389140B1 (ko) 2003-06-25
US20020137739A1 (en) 2002-09-26
AU744636B2 (en) 2002-02-28
PT1026167E (pt) 2003-07-31
US7238812B2 (en) 2007-07-03
JP3188482B2 (ja) 2001-07-16
NO20043765L (no) 2000-05-18
TR200000808T2 (tr) 2000-08-21
CN1523019A (zh) 2004-08-25
NO20001500L (no) 2000-05-18
HUP0004020A2 (hu) 2001-09-28
BR9814055A (pt) 2000-09-26
HK1032782A1 (en) 2002-08-30
CN1278262A (zh) 2000-12-27
ID24101A (id) 2000-07-06
ATE233764T1 (de) 2003-03-15
EP1026167A1 (en) 2000-08-09
CN1155599C (zh) 2004-06-30
CN1312135C (zh) 2007-04-25
RU2198885C2 (ru) 2003-02-20
CA2305307C (en) 2004-11-30
BR9814055B1 (pt) 2009-05-05
US20060074074A1 (en) 2006-04-06
US6372735B1 (en) 2002-04-16
PL339544A1 (en) 2000-12-18
US7022860B2 (en) 2006-04-04
DE69811930T2 (de) 2003-12-18
SK4252000A3 (en) 2000-10-09
EP1026167B1 (en) 2003-03-05
HUP0004020A3 (en) 2002-12-28
NO20001500D0 (no) 2000-03-23
DK1026167T3 (da) 2003-05-26
AU9186998A (en) 1999-04-23
SK283869B6 (sk) 2004-03-02
NZ503601A (en) 2002-02-01
DE69811930D1 (de) 2003-04-10

Similar Documents

Publication Publication Date Title
ES2185338T3 (es) Derivados de fumagilol y procedimientos para su fabricacion.
ES2182535T3 (es) Derivados de benzo(b)tiepina-1,-dioxido, procedimiento para su preparacion, medicamentos que contienen estos compuestos y su utilizacion.
ES2188016T3 (es) Derivaqdo de benzamidoxima, productos intermedios y procedimiento para su obtencion y su empleo como fungicidas.
CO4700455A1 (es) Derivados tetraciclicos y proceso para su preparacion
CO5721002A2 (es) Derivados de acido 3-(4-benciloxifenil) propanoico
AR009413A1 (es) Un compuesto, el cual es un derivado de distamicina benzoheterociclico, su utilizacion, un procedimiento para producirlo y una composicionfarmaceutica que lo comprende
AR039665A1 (es) Fenilacetamidas sustituidas y su uso como activadores de glucoquinasa
ES2193990T3 (es) Derivados de purina.
MX9202288A (es) Nuevos derivados de per hidro iso indol y procedimiento para su preparacion.
AR044796A1 (es) Derivados de pirido (2, 1-a) isoquinolina como inhibidores de la dpp iv
ECSP088149A (es) 3-acilaminobenzanilidas insecticidas
ES2192183T3 (es) Derivados de imidazopiridina como inhibidores de fosfodiesterasa vii.
ECSP082712A (es) Procedimiento i para preparar derivados de tiazolidindiona
ES2039242T3 (es) Un procedimiento para la preparacion de nuevos derivados de piperidina.
AR043055A1 (es) Derivados de 1-(4-benzil-piperazin-1-il)-3- fenil-propenona
CO5550437A2 (es) Compuestos quimicos
ES2182546T3 (es) Imidazo(1,2a)azinas sustituidas como inhibidores selectivos de la cox-2.
UY23718A1 (es) Procedimiento para la preparacion de derivados de octahidro- fenantreno
CO4920224A1 (es) Compuestos de pirrolidinil y pirrolinil etilamina como agonistas kappa
ECSP941050A (es) Derivados de benzofurano, proceso para su preparacion y composicion farmaceutica que los contiene
ECSP013947A (es) Compuestos estrogénicos
HRP20010630B1 (hr) Derivati 4-heterociklil-sulfonamidil-6-metoksi-5-(2-metoksi-fenoksi)-2-piridil-pirimidina, njihova proizvodnja i upotreba kao endotelin receptor antagonista
ES2188515T3 (es) Derivados de 22r-hidroxicolesta-8,14-dieno con actividad inhibidora de la meiosis.
AR003812A1 (es) Uso de los compuestos de 2-fenil-3-benzoil-benzotiofeno-6-sustituidos y sus sales farmaceuticamente aceptables para inhibir el inhibidor de activacion delplasminogeno 1.
CO4890850A1 (es) Derivados de 6-pirrolidin-2-ilpiridinas, su reparacion y preparacion en terapeutica.